EP0607775A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of leflunomid for the inhibition of interleukin 1 beta
Assignee: Hoechst AG
•
Filing: 1994-01-03
•
Granted: —
•
Expires: 2014-01-03
Abstract
Abstract N-(4-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide is an effective compound for preventing and treating diseases in which interleukin 1 beta is involved. It is used as pharmaceutical.
Inventors
- 👤 Klaus Ulrich Dr. Weithmann
- 👤 Robert Ryder Dr. Bartlett
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-07 22:31
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/275; A61K31/33; A61K31/395; A61K31/41; A61K31/42; A61P; A61P1/00; A61P1/16; A61P25/00; A61P25/28; A61P29/00; A61P3/00; A61P3/06; A61P31/00; A61P31/04; A61P31/12; A61P35/00; A61P35/02; A61P43/00; A61P7/00; A61P7/02; A61P9/00; A61P9/10
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.